First medicine receives general reimbursement after confidential price negotiation

NICE opens routine NHS access to SMA treatments

NICE approves givinostat for Duchenne muscular dystrophy

TLV to host seminar on U.S. MFN policy

Danish Medicines Council decisions from April 2026

Breaking: Denmark speeds up access to PD-(L)1 immunotherapies

Lif launches vaccine proposal: Denmark falls behind on vaccination efforts

NICE greenlights Rystiggo for uncontrolled gMG via interim NHS funding

Cancer care needs innovation that translates into real patient benefit

TLV revises guidelines to price adjustments for high sales value